Scientific Concept

The scientific focus of TheRNAtik is to provide expertise in the application and better understanding of RNA-based immunotherapies for the treatment of tumors and immune-mediated diseases. Particular attention is paid to the following topics:

  • RNA-based vaccines for cancer immunotherapy
  • RNA-based vaccines to combat infectious diseases
  • RNA-based vaccines for the treatment of allergies and autoimmune diseases
  • Protein replacement therapies in immune-mediated diseases
  • RNA-mediated reprogramming of immune cells for the treatment of tumors and immune-mediated diseases
  • Genome editing by RNA-encoded nucleases in immune cells.

Speakers:

Univ.-Prof. Dr. med. Özlem Türeci
Helmholtz-Institute for Translational Oncology Mainz (HI-TRON Mainz)

Univ.-Prof. Dr. rer. nat. Tobias Bopp
Institute of Immunology, University Medical Center Mainz

Contact:

Mainz Research School of Translational Biomedicine (TransMed)
E-Mail

"TheRNAtik" is funded by the Else Kröner-Fresenius-Stiftung.